348 related articles for article (PubMed ID: 26238331)
41. Kaempferide Prevents Titanium Particle Induced Osteolysis by Suppressing JNK Activation during Osteoclast Formation.
Jiao Z; Xu W; Zheng J; Shen P; Qin A; Zhang S; Yang C
Sci Rep; 2017 Nov; 7(1):16665. PubMed ID: 29192233
[TBL] [Abstract][Full Text] [Related]
42. Notoginsenoside R1 suppresses wear particle-induced osteolysis and RANKL mediated osteoclastogenesis in vivo and in vitro.
Zhao S; Yan L; Li X; Zhang Z; Sun Y; Wang J
Int Immunopharmacol; 2017 Jun; 47():118-125. PubMed ID: 28384530
[TBL] [Abstract][Full Text] [Related]
43. Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway.
Wu H; Hu B; Zhou X; Zhou C; Meng J; Yang Y; Zhao X; Shi Z; Yan S
Cell Death Dis; 2018 May; 9(5):498. PubMed ID: 29703893
[TBL] [Abstract][Full Text] [Related]
44. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
[TBL] [Abstract][Full Text] [Related]
45. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
46. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
47. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
48. Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss.
Zhang Y; Guan H; Li J; Fang Z; Chen W; Li F
Sci Rep; 2015 Sep; 5():13575. PubMed ID: 26338477
[TBL] [Abstract][Full Text] [Related]
49. Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis.
Chen X; Zhi X; Cao L; Weng W; Pan P; Hu H; Liu C; Zhao Q; Zhou Q; Cui J; Su J
Cell Death Dis; 2017 Sep; 8(9):e3037. PubMed ID: 28880271
[TBL] [Abstract][Full Text] [Related]
50. Vitexin suppresses RANKL-induced osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced osteolysis.
Jiang J; Jia Y; Lu X; Zhang T; Zhao K; Fu Z; Pang C; Qian Y
J Cell Physiol; 2019 Aug; 234(10):17549-17560. PubMed ID: 30793311
[TBL] [Abstract][Full Text] [Related]
51. Bulleyaconitine A prevents Ti particle-induced osteolysis via suppressing NF-κB signal pathway during osteoclastogenesis and osteoblastogenesis.
Zhang L; Feng M; Li Z; Zhu M; Fan Y; Chu B; Yuan C; Chen L; Lv H; Hong Z; Hong D
J Cell Physiol; 2018 Sep; 233(9):7067-7079. PubMed ID: 29388671
[TBL] [Abstract][Full Text] [Related]
52. A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways.
Liu Y; Liu W; Yu Z; Zhang Y; Li Y; Xie D; Xie G; Fan L; He S
Cell Death Dis; 2021 Jun; 12(7):654. PubMed ID: 34175898
[TBL] [Abstract][Full Text] [Related]
53. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
54. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
55. Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis.
Li H; Wang J; Sun Q; Chen G; Sun S; Ma X; Qiu H; Liu X; Xu L; Liu M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469456
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis.
Li M; Wang W; Geng L; Qin Y; Dong W; Zhang X; Qin A; Zhang M
Int J Mol Med; 2015 Nov; 36(5):1335-44. PubMed ID: 26324422
[TBL] [Abstract][Full Text] [Related]
57. Gambogic acid inhibits osteoclast formation and ovariectomy-induced osteoporosis by suppressing the JNK, p38 and Akt signalling pathways.
Ma J; Ma Y; Liu X; Chen S; Liu C; Qin A; Fan S
Biochem J; 2015 Aug; 469(3):399-408. PubMed ID: 26205493
[TBL] [Abstract][Full Text] [Related]
58. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.
Liu Y; Wang C; Wang G; Sun Y; Deng Z; Chen L; Chen K; Tickner J; Kenny J; Song D; Zhang Q; Wang H; Chen Z; Zhou C; He W; Xu J
Theranostics; 2019; 9(16):4648-4662. PubMed ID: 31367247
[No Abstract] [Full Text] [Related]
59. Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathways.
Liao S; Feng W; Liu Y; Wang Z; Ding X; Song F; Lin X; Song H; Kc A; Su Y; Liang J; Xu J; Liu Q; Zhao J
J Cell Physiol; 2021 Feb; 236(2):1432-1444. PubMed ID: 32853427
[TBL] [Abstract][Full Text] [Related]
60. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
